154 related articles for article (PubMed ID: 2007290)
21. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K; Yamamoto A; Ogawa N; Sekine T; Tamai S; Motoyama O
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study.
Harada K; Akai Y; Kurumatani N; Iwano M; Saito Y
Nephron; 2002 Dec; 92(4):824-6. PubMed ID: 12399627
[TBL] [Abstract][Full Text] [Related]
23. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
24. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
25. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
26. Influence of cytokine gene polymorphisms on IgA nephropathy.
Bantis C; Heering P; Aker S; Kuhr N; Grabensee B; Ivens K
Ren Fail; 2008; 30(2):135-40. PubMed ID: 18300111
[TBL] [Abstract][Full Text] [Related]
27. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
28. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese.
Kusumoto Y; Takebayashi S; Taguchi T; Harada T; Naito S
Clin Nephrol; 1987 Sep; 28(3):118-24. PubMed ID: 3665204
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy.
Tateno S; Kobayashi Y
Nephron; 1987; 46(1):28-33. PubMed ID: 3600909
[TBL] [Abstract][Full Text] [Related]
30. Urine interleukin-8 as a marker of vesicoureteral reflux in infants.
Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276
[TBL] [Abstract][Full Text] [Related]
31. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
Ranieri E; Gesualdo L; Petrarulo F; Schena FP
Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
[TBL] [Abstract][Full Text] [Related]
32. Urinary kallikrein excretion and renal interstitial damage in mesangial proliferative glomerulonephritis.
Hara M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):553-60. PubMed ID: 3656713
[No Abstract] [Full Text] [Related]
33. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
Muda AO; Feriozzi S; Rahimi S; Faraggiana T
J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
[TBL] [Abstract][Full Text] [Related]
34. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
Wu TH; Wu SC; Huang TP; Yu CL; Tsai CY
Nephron; 1996; 74(1):79-88. PubMed ID: 8883024
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of mesangial sclerosis in IgA nephropathy.
Shigematsu H; Kobayashi Y; Tateno S; Hiki Y
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):303-9. PubMed ID: 4021194
[No Abstract] [Full Text] [Related]
36. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
[TBL] [Abstract][Full Text] [Related]
37. Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.
Tomino Y; Funabiki K; Ohmuro H; Shimizu M; Yokoyama K; Shirato I; Shirai T; Takahashi M; Koide H
Am J Nephrol; 1991; 11(6):459-64. PubMed ID: 1819212
[TBL] [Abstract][Full Text] [Related]
38. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
[TBL] [Abstract][Full Text] [Related]
39. [Semiquantitative histological evaluation of IgA nephropathy and Cox's proportional Hazzard model analysis].
Nakao N
Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1063-70. PubMed ID: 1808358
[TBL] [Abstract][Full Text] [Related]
40. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
Kalliakmani P; Nakopoulou L; Tsakas S; Gerolymos M; Papasotiriou M; Goumenos DS
Clin Nephrol; 2011 Aug; 76(2):144-50. PubMed ID: 21762647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
